Quick Diagnostics Of New Infectious Coronavirus
Diagnostik Cepat dari Penularan Virus Corona
-
(1) * Boboev Muhammadayubkhon Murodkhonovich
Tashkent Pharmaceutical Institute
Uzbekistan
(2) Ramazonova Shahzoda Tashkent Pharmaceutical Institute
Uzbekistan
(*) Corresponding Author
Abstract
The emergence in December 2019 of diseases caused by the new coronavirus (2019-nCoV) posed difficult challenges for healthcare professionals and doctors related to the rapid diagnosis and clinical management of patients with this infection.
References
Erofeeva, M.K., Maksakova, V. L., Shelekhova, S. E., & Pozdnyakova, M. G. (2012). Possibility of using Nazaval Plus for the prevention of acute respiratory infections in children // Infection and immunity. Vol 2012, 1-2. Retrieved from https://cyberleninka.ru/article/n/vozmozhnost-primeneniya-preparata-nazaval-plyus-dlya-profilaktiki-ostryh-respiratornyh-zabolevaniy-u-detey
Omrani, A. S., Saad, M. M., Baig, K., & Bahloul, A., … Albarrak, A. M. (2014). Ribavirin and interferonalfa-2aforsevere Middle East respiratory syndrome ecorona virus infection: aretro spective cohort study. Lancet Infect Dis, 14 (11), 1090-1095. doi: 10.1016/S1473-3099(14)70920-X
Osidak L.V., & Obraztsova E.V. (2012). The effectiveness of the inosine pranobex molecule in therapeutic and pediatric practice. Epidemiology of Infectious Diseases. 2012(4), 26-32. Retrieved from https://epidemiology-journal.ru/en/archive/article/11472
WHO (World Health Organization). (2019). Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: Interim Guidance. Updated 2 January 2019. Retrieved From https://apps.who.int/iris/bitstream/handle/10665/178529/WHO_MERS_Clinical_15.1_eng.pdf?sequence=1&isAllowed=y
